Increased expression of other tyrosine kinases

Altered expression of drug transporter proteins

The Bcr-Abl threonine residue in the kinase domain is mutated to an isoleucine (T315I) which blocks Glivec access to Bcr-Abl

Amplification of Bcr-Abl